Alliance Transfusion Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 14 Year, 21 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.60 M
as on 17-07-2024
- Revenue -41.00%
(FY 2023)
- Profit -82.43%
(FY 2023)
- Ebitda 23.18%
(FY 2023)
- Net Worth 1.68%
(FY 2023)
- Total Assets -3.88%
(FY 2023)
About Alliance Transfusion
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.60 M.
Nupur Bhatnagar and Kartik Jain serve as directors at the Company.
- CIN/LLPIN
U85100HR2010PTC041650
- Company No.
041650
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alliance Transfusion Private Limited offer?
Alliance Transfusion Private Limited offers a wide range of products and services, including Medical Equipment & Accessories, Medical Equipment, Rapid Test Kit, Vein Viewer, Medical Laboratory Instruments, Corona Test Kit, Medical Tubes, Blood Transfusion Set.
Who are the key members and board of directors at Alliance Transfusion?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nupur Bhatnagar  | Director | 02-Dec-2010 | Current |
| Kartik Jain | Director | 14-Aug-2012 | Current |
Financial Performance of Alliance Transfusion.
Alliance Transfusion Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41% decrease. The company also saw a substantial fall in profitability, with a 82.43% decrease in profit. The company's net worth moved up by a moderate rise of 1.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alliance Transfusion?
In 2023, Alliance Transfusion had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Mar 2021 | ₹8.60 M | Open |
How Many Employees Work at Alliance Transfusion?
Unlock and access historical data on people associated with Alliance Transfusion, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alliance Transfusion, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alliance Transfusion's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
